IN
Healthcare & Life Sciences
Invirsa
United Statesinvirsa.com
Invirsa is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Invirsa
Invirsa is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Invirsa develops INV-102, a drug compound that enhances the body's response to DNA damage to treat ocular conditions such as sulfur mustard gas injury and diabetic dry eye disease.
Explore Invirsa's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.